New Type 2 Diabetes Medication Now Available

The U.S. Food and Drug Administration has approved the use of Adlyxin(lixisenatide) which is the  injectable drug use to treat type 2 diabetes in  adults.The drug is injected once daily and is used together with diet and exercise for its effectiveness to improve blood sugar level in patients.After the reviewed 10 clinical trials FDA concluded that Adlyxin helps to normalize blood sugar level.

Adlyxin belong to a class of drugs called glucagon-like peptide-1(GLP-1)receptor agonists.Adlyxin is not suppose to be used by patients with type 1 diabetes and those with high levels of ketones in their blood or urine.

Some common side effects associated with Adlyxin include vomiting,headache,dizziness,diarrhea and nausea as reported by FDA.Hypoglycemia(low blood sugar) occurred in patients who took both Adlyxin and other diabetes drugs such as sulfonylureas.Some people also showed severe  hypersensitiveness and also serious allergic reaction.

This drug will boost health of type 2 diabetes despite having some side effects considering that over 29 million people in American alone have type 2 diabetes which is over 90% of diabetes cases.

Author: healthfeels

Medical Researcher and Author based in Nairobi.Writing about health matters.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s